HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Olay Professional Pro-X Performs On Par With Top Rx Brand, At Half The Price?

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble is going after consumers who demand a bang for their buck with its wrinkle-targeting Olay Professional Pro-X line, which it claims offers Rx results at a much-reduced price

You may also be interested in...



In Brief: FDA Cosmetics Twitter; Eyebrow Makeup Sales; Olay ProX Study

FDA’s Office of Cosmetics and Colors starts tweeting, NPD says prestige eyebrow makeup sales are an opportunity for growth. More news in brief.

Olay Enters Acne Treatment With Pro-X Clear, Formulated For Adults

Olay Professional Pro-X Clear, the first acne treatment line under the venerable Procter & Gamble brand, is positioned as a range that meets the needs of adult skin.

Olay Enters Acne Treatment With Pro-X Clear, Formulated For Adults

Olay Professional Pro-X Clear, the first acne treatment line under the venerable Procter & Gamble brand, is positioned as a range that meets the needs of adult skin.

Related Content

UsernamePublicRestriction

Register

RS016010

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel